Significance of initial, interim and end-of-therapy 18F-FDG PET/CT for predicting transformation risk in follicular lymphoma.

Mixue XieLulu WangQi JiangXuxia LuoXin ZhaoXueying LiJie JinXiu-Jin YeKui Zhao

Published in: Cancer cell international (2021)

In follicular lymphoma, quantitative assessment used SUVmax at the pre-treatment and end-of-treatment PET/CT scan may be helpful for early screen out patients at high risk of transformation and guide treatment decisions.

Keyphrases

pet ct
computed tomography
magnetic resonance
mesenchymal stem cells
contrast enhanced